Similar Stories
Sources
- Semafor Africa
South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist to develop groundbreaking gene therapy treatments that target diseases that have plagued Africa for decades. https://t.co/iKRPrACOqO
- Yinka Adegoke
South Africa’s Afrigen is betting on mRNA vaccines to beat diseases like sickle cell, Rift Valley fever, malaria, and tuberculosis https://t.co/DeonntAjUm via @SemaforAfrica
- Semafor Africa
South Africa’s Afrigen targets local diseases with mRNA vaccines https://t.co/iKRPrADmgm
- Yinka Adegoke
SCOOP 🟡South Africa’s Afrigen targets local diseases with mRNA vaccines, @alexisak https://t.co/DeonntzM4O
- Alexis Akwagyiram
SCOOP: South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team to develop groundbreaking gene therapy treatments that target diseases that have plagued Africa for decades. https://t.co/AZp6cIQ6hP
- Semafor
🟡 SCOOP: South Africa's Afrigen is collaborating with a Nobel Prize-winning scientist to develop mRNA vaccines that target diseases that have plagued Africa for decades, @alexisak reports. https://t.co/RaLCrZiBai